We are live on ! Find out more
EWTX icon

Edgewise Therapeutics
EWTX

72 hedge funds and large institutions have $524M invested in Edgewise Therapeutics in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

24% more funds holding

Funds holding: 58 → 72 (+14)

6.9% more ownership

Funds ownership: 102.09% → 109% (+6.9%)

32% less capital invested

Capital invested by funds: $769M → $524M (-$246M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
72
Holders Change
+14
Holders Change %
+24.14%
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
25
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$14.4M
2
EC
EcoR1 Capital
California
+$13.9M
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$8.53M
4
DCM
DAFNA Capital Management
California
+$4.59M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.5M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$8.19M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.39M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$2.25M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.2M
5
WP
Woodline Partners
California
-$550K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$2.13M +$2.83M +219,960 New
LGM
27
Logos Global Management
California
$2.07M -$8.19M -636,256 -75%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.07M -$20.9K -1,626 -0.8%
Charles Schwab
29
Charles Schwab
California
$1.41M +$63.2K +4,910 +3%
LCM
30
Laurion Capital Management
New York
$1.37M +$1.81M +140,972 New
Goldman Sachs
31
Goldman Sachs
New York
$1.28M +$1.18M +91,654 +226%
N
32
Nuveen
North Carolina
$1.15M +$216K +16,765 +18%
Millennium Management
33
Millennium Management
New York
$592K +$785K +60,992 New
TCM
34
Tekla Capital Management
Massachusetts
$587K – – –
HS
35
HighVista Strategies
Massachusetts
$579K +$769K +59,733 New
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$502K +$461K +35,800 +224%
CSS
37
Cubist Systematic Strategies
Connecticut
$391K +$519K +40,303 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$358K +$81.7K +6,350 +21%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$273K +$125K +9,714 +53%
Bank of America
40
Bank of America
North Carolina
$267K -$15.9K -1,236 -4%
JP Morgan Chase
41
JP Morgan Chase
New York
$263K +$66.4K +5,156 +23%
Walleye Capital
42
Walleye Capital
New York
$244K +$324K +25,196 New
MIM
43
MetLife Investment Management
New Jersey
$227K +$107K +8,328 +55%
QPW
44
Quantum Private Wealth
Florida
$215K +$37.2K +2,890 +15%
TI
45
Trexquant Investment
Connecticut
$215K +$105K +8,189 +58%
Deutsche Bank
46
Deutsche Bank
Germany
$214K -$32.2K -2,498 -10%
Morgan Stanley
47
Morgan Stanley
New York
$214K +$61.8K +4,798 +28%
UBS Group
48
UBS Group
Switzerland
$214K +$284K +22,047 New
AIG
49
American International Group
New York
$186K -$17.4K -1,351 -7%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$183K +$23.2K +1,800 +10%
1
2
3 4

EWTX Hedge Fund Activity: Q1 2022 in Review

72 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q1 2022, worth a combined $524M — down 32% from $769M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new EWTX positions and 4 closed out — a net gain of 14 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $14.4M. The largest seller was Logos Global Management, cutting an estimated $8.19M.

  • 72 institutional investors held Edgewise Therapeutics (EWTX) as of Q1 2022, up from 58 in Q4 2021.
  • Funds reported $524M of Edgewise Therapeutics stock for Q1 2022, down 32% quarter-over-quarter.
  • 18 funds opened new Edgewise Therapeutics positions in Q1 2022 and 4 closed out, a net change of +14 holders.
  • The largest Edgewise Therapeutics buyer in Q1 2022 was Cormorant Asset Management, an estimated $14.4M added.
  • The largest Edgewise Therapeutics seller in Q1 2022 was Logos Global Management, an estimated $8.19M sold.

Based on aggregated 13F filings for Q1 2022.